-+ 0.00%
-+ 0.00%
-+ 0.00%

Palvella Therapeutics director John Doux files initial beneficial ownership statement

PUBT·04/15/2026 20:06:04
Listen to the news
Palvella Therapeutics director John Doux files initial beneficial ownership statement
  • Palvella Therapeutics director John Doux reported a fully vested stock option for 10,364 common shares at USD 7.14, expiring Feb. 4, 2030.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-043788), on April 15, 2026, and is solely responsible for the information contained therein.